OTC : AMBFF

Ambu A/S

$9.85 USD

$0 (0.0%)

Volume
197
Average Volume
26
Market Capitalization
$2.59B
P/E Ratio
38.29
Dividend Yield
0.60%
Price Target
Year High
$15.41
Year Low
$9.40
Day High
—
Day Low
—
Payout Ratio
$0.23
Current Ratio
$2.92
Company Overview

OTC

Britt Meelby Jensen

Medical - Devices

Healthcare

AMBFF

5000

DK

USD

https://www.ambu.com

45 72 25 20 00

N/A

N/A

Liquidity Metrics

0.09

2.92

1.73

0.67

0.23

Sales & Valuation

$6.03B

2.97

2.98

35.10

1.94

Profitability

$2.28

$607.84M

7.81%

10.16%

7.92%

6.27%

P/E Metrics

38.29

1.32

1.32

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

9.24

6/9

$1.98B

$7.61B

$1.51B

$664.51M

Key Metrics (TTM)

$17.97B

2.94

17.30

2.92

7.92%

7.56%

2.63%

2.85%

$30.36

154 days

Company Executives
Name Title
Jesper Johnsen Steen Chief Marketing Officer
Thomas Lykke Henriksen Head of HR Systems
Holger Hesse Founder
Henrik Skak Bender Chief Financial Officer
Sanne Kjærsgaard Hjordrup Chief People & Culture Officer
Anders Hjort Head of Investor Relations
Finn Mohring Chief Technology Officer
Graziela Chaluppe dos Santos Malucelli Chief Operations Officer
Tine Bjorn Schmidt Head of Corporate Communications
Britt Meelby Jensen Chief Executive Officer
Poll Results

No votes yet today — be the first to share your view!

About Ambu A/S (OTC:AMBFF) Stock

Established in 1937 and headquartered in Ballerup, Denmark, Ambu A/S specializes in the global development, manufacturing, and distribution of medical devices. These critical instruments and solutions are supplied to hospitals, clinics, and emergency medical services across the globe. Ambu's comprehensive portfolio addresses key areas of healthcare, including medical visualization, anesthesia, patient monitoring, and diagnostics. Its product lines encompass a wide array of specialized equipment. For endoscopy, offerings include bronchoscopes and associated monitoring systems. In the field of neurology, Ambu provides EEG and EMG electrodes, devices for EMG-guided injections, and intraoperative monitoring tools. Cardiology departments benefit from its range of ECG electrodes. Furthermore, th ... e company delivers an extensive suite of airway management and anesthesia products, such as various bronchoscopes, video laryngoscopes, single and double lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and manual resuscitators. Rounding out its offerings are essential items like extrication collars, CPR breathing barriers, and training manikins.

Frequently Asked Questions

What is the current Ambu A/S (AMBFF) stock price?

Ambu A/S(OTC:AMBFF) stock price is $9.85 in the last trading session. During the trading session, AMBFF stock reached the peak price of $15.4062 while $9.4 was the lowest point it dropped to. The percentage change in AMBFF stock occurred in the recent session was 0.0% while the dollar amount for the price change in AMBFF stock was $0.

AMBFF's industry and sector of operation?

The OTC listed AMBFF is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of AMBFF?

Jesper Johnsen Steen | Chief Marketing Officer
Thomas Lykke Henriksen | Head of HR Systems
Holger Hesse | Founder
Henrik Skak Bender | Chief Financial Officer
Sanne Kjærsgaard Hjordrup | Chief People & Culture Officer

How many employees does AMBFF have?

Number of AMBFF employees currently stands at 5000. AMBFF operates from Baltorpbakken 13, Ballerup, CR 2750, DK.

Link for AMBFF official website?

Official Website of AMBFF is: https://www.ambu.com

How do I contact AMBFF?

AMBFF could be contacted at phone #45 72 25 20 00 and can also be accessed through its website. AMBFF operates from Baltorpbakken 13, Ballerup, CR 2750, DK.

How many shares of AMBFF are traded daily?

The average number of AMBFF shares traded daily for last 3 months was 26.

What is the market cap of AMBFF currently?

The market value of AMBFF currently stands at $2.59B with its latest stock price at $9.85